Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DYRK1A | Q13627 | 11/20 | 0.61 |
| ▸ | DYRK1B | Q9Y463 | 10/20 | 0.61 |
| ▸ | DYRK2 | Q92630 | 7/20 | 0.61 |
| ▸ | ERN1 | O75460 | 3/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.53 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.53 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.53 |
| ▸ | CLK1 | P49759 | 6/20 | 0.53 |
| ▸ | CLK2 | P49760 | 4/20 | 0.51 |
| ▸ | CLK3 | P49761 | 2/20 | 0.51 |
| ▸ | CSNK2A2 | P19784 | 2/20 | 0.51 |
| ▸ | CSNK2B | P67870 | 2/20 | 0.51 |
| ▸ | CSNK2A1 | P68400 | 2/20 | 0.51 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.51 |
| ▸ | PRKCI | P41743 | 1/20 | 0.47 |
| ▸ | DYRK3 | O43781 | 4/20 | 0.44 |
| ▸ | CLK4 | Q9HAZ1 | 3/20 | 0.44 |
| ▸ | DYRK4 | Q9NR20 | 3/20 | 0.44 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.44 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL8556367 | 0.96 | DYRK1A (0.58) | DYRK1ADYRK1BDYRK2ERN1ALDH1A1 | |
| Hydrochloric Acid SCHEMBL8556369 | 0.96 | DYRK1A (0.58) | DYRK1ADYRK1BDYRK2ERN1ALDH1A1 | |
| SCHEMBL3328614 | 0.89 | DYRK1A (0.61) | DYRK1ADYRK1BDYRK2ERN1ALDH1A1 | |
| SCHEMBL29957044 | 0.89 | DYRK1A (0.61) | DYRK1ADYRK1BDYRK2ERN1ALDH1A1 | |
| SCHEMBL3517912 | 0.87 | DYRK1A (0.56) | DYRK1ADYRK1BDYRK2ERN1ALDH1A1 | |
| Anisaldehyde SCHEMBL28290436 | 0.86 | ALDH1A1 (0.54) | DYRK1ADYRK1BDYRK2ERN1ALDH1A1 | |
| SCHEMBL30679660 | 0.86 | ERN1 (0.64) | DYRK1ADYRK1BDYRK2ERN1ALDH1A1 | |
| SCHEMBL2416319 | 0.85 | ALDH1A1 (0.53) | DYRK1ADYRK1BDYRK2ERN1ALDH1A1 | |
| SCHEMBL1647020 | 0.82 | DYRK1A (0.55) | DYRK1ADYRK1BDYRK2ERN1CLK1 | |
| SCHEMBL29585187 | 0.82 | DYRK1A (0.55) | DYRK1ADYRK1BDYRK2ERN1CLK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 810 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250075147-A1 | FRAGRANCE AND FLAVOR COMPOSITIONS COMPRISING NEW FLAVOR AND FRAGRANCE INGREDIENTS | OSMO LABS, PBC | 2025-03-06 | — | — | US | claimed |
| CN-119219504-A | Method for synthesizing triarylmethane molecular skeleton by aromatic aldehyde and hydrazine hydrochloride substance | 山东金科力电源科技有限公司 | 2024-12-31 | — | — | CN | claimed |
| CN-114656455-B | Triazole modified ferric oxide photocatalyst and preparation method thereof | 常熟华虞环境科技有限公司 | 2022-08-09 | — | — | CN | claimed |
| CN-114656455-A | Triazole modified ferric oxide photocatalyst and preparation method thereof | 常熟华虞环境科技有限公司 | 2022-06-24 | — | — | CN | claimed |
| WO-2010041271-A2 | PROCESS FOR PREPARATION OF (S)-N-[2-(1,6,7,8-TETRAHYDRO-2H-INDENO[5,4-B]FURAN-8-YL)ETHYL] PROPIONAMIDE AND NOVEL INTERMEDIATES THEREOF | USV LIMITED (IN) | 2010-04-15 | — | — | WO | claimed |
| EP-1891034-A2 | PROCESSES FOR PREPARING DARIFENACIN HYDROBROMIDE | Teva Pharmaceutical Fine Chemicals S.R.L. (IT) | 2008-02-27 | — | — | EP | claimed |
| US-20070197631-A1 | Processes for preparing darifenacin hydrobromide | TEVA PHARMACEUTICAL INDUSTRIES LTD. (IL) | 2007-08-23 | — | — | US | claimed |
| WO-2007076157-A2 | PROCESSES FOR PREPARING DARIFENACIN HYDROBROMIDE | TEVA PHARMACEUTICALS INDUSTRIES LTD. (IL) | 2007-07-05 | — | — | WO | claimed |
| US-20070130702-A1 | Dyeing process using a specific compound containing active methylene and a compound chosen from a specific aldehyde, a specific ketone, a quinone and a diiminoisoindoline or 3-aminoisoindolone derivative | L'OREAL S.A. | 2007-06-14 | — | — | US | claimed |
| US-7204857-B1 | Dyeing method using a specific active methylene compound and a compound selected among a specific aldehyde, a specific ketone, a quinone and a di-imino-isoindoline or 3-amino-isoindolone derivative | L'OREAL S.A. (FR) | 2007-04-17 | — | — | US | claimed |
| EP-1292268-B1 | AGENT FOR DYEING KERATIN CONTAINING FIBERS | HENKEL KGAA (DE) | 2005-02-23 | — | — | EP | claimed |
| EP-1292269-B1 | AGENT FOR DYEING KERATIN CONTAINING FIBERS | HENKEL KGAA (DE) | 2005-02-09 | — | — | EP | claimed |
| US-6790239-B1 | COMBINATION OF AROMATIC ALDEHYDES OR KETONES AND CH-ACTIVE COMPOUNDS | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2004-09-14 | — | — | US | claimed |
| US-6635090-B1 | Dyeing method using a specific cationic derivative and a compound selected among a specific aldehyde, a specific ketone, a quinone and a di-imino-isoindoline or 3-amino-isoindolone derivative | L'OREAL, S.A. (FR) | 2003-10-21 | — | — | US | claimed |
| EP-1292269-A1 | AGENT FOR DYEING KERATIN CONTAINING FIBERS | Henkel Kommanditgesellschaft auf Aktien (DE) | 2003-03-19 | — | — | EP | claimed |
| US-6458168-B1 | Hair dyeing method using an aliphatic cationic amine and compound chosen from an aldehyde, a ketone, a quinone, a di-imino-isoindoline, and a 3-aminoisoindolone derivative | L'OREAL S.A. (FR) | 2002-10-01 | — | — | US | claimed |
| US-6451067-B1 | HAIR DYE MIXTURE | L'OREAL S.A. (FR) | 2002-09-17 | — | — | US | claimed |
| EP-1235549-A1 | AGENT FOR COLOURING KERATIN CONTAINING FIBRES | Henkel Kommanditgesellschaft auf Aktien (DE) | 2002-09-04 | — | — | EP | claimed |
| WO-2001097765-A1 | AGENT FOR DYEING KERATIN CONTAINING FIBERS | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2001-12-27 | — | — | WO | claimed |
| WO-2001034106-A1 | AGENT FOR COLOURING KERATIN CONTAINING FIBRES | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2001-05-17 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070130702-A1 | Dyeing process using a specific compound containing active methylene and a compound chosen from a specific aldehyde, a specific ketone, a quinone and a diiminoisoindoline or 3-aminoisoindolone derivative | KRT18, NDUFB5, NDUFB7 | DYRK1A 2614/4885DYRK1B 2366/4885DYRK2 2511/4885 |
| US-20070197631-A1 | Processes for preparing darifenacin hydrobromide | OPRL1, AVPR2, AVPR1B | DYRK1A 1395/4885DYRK1B 1310/4885DYRK2 1486/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.